Sotalol hydrochloride
-
Sotalol hydrochloride
structure -
-
CAS No:
959-24-0
-
Formula:
C12H20N2O3S.ClH
-
Chemical Name:
Sotalol hydrochloride
-
Synonyms:
Methanesulfonamide,N-[4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]phenyl]-,hydrochloride (1:1);Methanesulfonanilide,4′-[1-hydroxy-2-(isopropylamino)ethyl]-,monohydrochloride;Methanesulfonamide,N-[4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]phenyl]-,monohydrochloride;4′-[1-Hydroxy-2-(isopropylamino)ethyl]methanesulfonanilide hydrochloride;4′-[2-(Isopropylamino)-1-hydroxyethyl]methanesulfonanilide hydrochloride;N-Isopropyl-β-(4-methanesulfonamidophenyl)ethanolamine hydrochloride;Sotalol hydrochloride;MJ 1999;4′-[2-(Isopropylamino)-1-hydroxyethyl]methanesulfonanilide monohydrochloride;Sotalex;Sotacor;DL-MJ 1999;(±)-Sotalol hydrochloride;dl-Sotalol hydrochloride;Betapace;Darob;Sotalol HCl;N-[4-[1-Hydroxy-2-[(1-methylethyl)amino]ethyl]phenyl]methanesulfonamide hydrochloride;4201-00-7
- Categories:
-
CAS No:
Description
Sotalol Hydrochloride is an adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.Target: Adrenergic ReceptorSotalol is a non-selective competitive β-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties by its inhibition of potassium channels. Sotalol is a competitive beta adrenoceptor antagonist devoid of membrane-stabilizing activity and intrinsic sympathomimetic activity that has no preferential actions on beta 1 or beta
Sotalol hydrochloride is a hydrochloride salt that is the monohydrochloride of sotalol. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias. It has a role as a beta-adrenergic antagonist and an anti-arrhythmia drug. It contains a sotalol(1+).|An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
Sotalol hydrochloride Basic Attributes
308.82
308.096130
213-496-0
760358|337251
DTXSID8021278
2935009090
Characteristics
86.8
3.43620
white to off-white powder
206.5-207 °C
443.3ºC at 760 mmHg
221.9ºC
soluble in phosphate buffered saline, DMSO, ethanol, water, and methanol.H2O: 20 mg/mL
Store at RT
Oral-rat LD50: 3450 mg/kg; Oral-Mouse LD50: 2600 mg/kg
Thermal decomposition to remove toxic nitrogen oxides, sulfur oxides, hydrogen chloride fumes
166.3 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Safety Information
NONH for all modes of transport
3
36/37/38
26-36
PB0826000
Xi
The warehouse is low-temperature, ventilated and dry
P261-P305 + P351 + P338
H315-H319-H335
|Warning|H315 (95.77%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 72 companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)|Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)|Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)
Darob
Sotalol hydrochloride Use and Manufacturing
A potent -adrenergic receptor antagonist.A class III antiarrythmic.It has been shown to prolong action potential and increases the refractory period
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:308.83
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:6
Exact Mass:308.0961414
Monoisotopic Mass:308.0961414
Topological Polar Surface Area:86.8
Heavy Atom Count:19
Complexity:330
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Extract from the above information
Registered Holders
-
Cambrex Profarmaco Milano S.r.l.
Active
Japan
-
CAMBREX PROFARMACO MILANO SRL
Active
Brazil
-
Shandong Luoxin Pharmaceutical Group HENGXIN Pharmaceutical Co., Ltd.
Active
China
Recommended Suppliers of Sotalol hydrochloride
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of fine chemicals,pharmaceutical materials
Learn More Other Chemicals
-
4H-1-Benzopyran-4-one, 2-[4-[3-(dibutylamino)propoxy]-3,5-dimethylbenzoyl]-, hydrochloride (1:1)
67652-33-9
-
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, hydrochloride (9CI)
681807-60-3
-
CYCLOPENTYL-(3,4,5-TRIMETHOXY-BENZYL)-AMINE HYDROCHLORIDE
1052525-88-8
-
2-Cyclopropylbenzenemethanamine hydrochloride Formula
118184-64-8
-
Des[4-(2-cycloproylMethoxy)] Betaxolol Hydrochloride Formula
464877-45-0
-
Ethanamine, 2-(decylthio)-, hydrochloride (1:1) Formula
36362-09-1
-
4,7-Dichloro-2-propylquinoline hydrochloride Structure
1204812-22-5
-
6,7-Dichloro-4-hydrazino-2-methylquinoline hydrochloride Structure
1170377-12-4
-
What is 2,8-Diazaspiro[4.5]decan-1-one, 2-[(4-bromophenyl)methyl]-, hydrochloride (1:1)
832710-56-2
-
What is 6,7-Dichloro-4-hydrazinoquinoline hydrochloride
1171843-02-9